Allergic rhinitis affects millions of children and adults. Indeed, it is the fifth most common chronic disease in the United States. Although people do not die from allergic rhinitis, it sure can make you feel miserable, disturb sleep, and impair daily activities. Guidelines recommend the use of intranasal corticosteroids on a daily basis since the onset of action takes a few days. In reality, however, patients adjust their treatment according to the severity of their symptoms. As-needed corticosteroid use is effective for the treatment and prevention of asthma symptoms. Can we apply this same concept to allergic rhinitis? Could the as-needed use of intranasal corticosteroids achieve the same outcomes as daily use?
Guest Authors: Lalitha Sukumar, PharmD; Alyssa Gallipani, PharmD, BCACP; and Rahul Jacob, PharmD
Music by Good Talk
LDL Limbo: How Low is Too Low?
Top Ten Things Every Clinician Should Know About the 2018 Antithrombotic Therapy Atrial Fibrillation Guidelines
Maybe Old is Gold? Newer Insulins Might Not Be Better – Just More Expensive
Using Controllers PRN for Mild Persistent Asthma – An Oxymoron?
The ZOE Trials – The Herpes Zoster Recombinant Subunit Vaccine — It’s Time to Upgrade!
Are You REAL-ly Paying Attention? The Importance of Attention Controls
Is it Time to “Step Up” Rescue Treatment for Asthma to Prevent Exacerbations?
Stop the Shots: Edoxaban vs Dalteparin in Cancer-Associated VTE Treatment
Hypertension – Time for Patients to Control the Wheel
Cutting Down HIV Treatment to a 2-Drug Regimen
Strategies for Managing Hypertension: Is the Paradigm Shifting?
Don’t Kid Yourself: Broad- versus Narrow-Spectrum Antibiotics in Children
Using Sotagliflozin In Tandem with Insulin: Weighing the Benefits in Type 1 Diabetes
Treating Opioid Use Disorder - X:BOT Offers a Pragmatic Approach
Can We KEEP Perimenopausal Women Sexually Satisfied?
Know When to Hold 'Em - Know When to Fold 'Em. Deprescribing in BPH.
ARCH Study: Is Romosozumab better than Alendronate for the Fracture-Prone?
SPRINTing towards lower BP goals : A re-analysis of the ACCORD-BP trial
Therapy for Early-Stage COPD: What is the GOLDen Regimen?
Inflammatory Statements about Cardiovascular Risk Reduction: The CANTOS Trial
Create your
podcast in
minutes
It is Free
Good Mood Revolution
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
Precision Medicine Forum Podcast
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive